Click Here for 5% Off Your First Aladdin Purchase!

GDC-0134 , CAS No.G610529, Inhibitor of mitogen-activated protein kinase kinase kinase 12

  • Moligand™
Item Number
G610529
Grouped product items
SKUSizeAvailabilityPrice Qty
G610529-5mg
5mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$1,334.90
G610529-25mg
25mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$2,000.90

Basic Description

SynonymsGDC-0134|UNII-4N6KQ7D685|RG-6000|4N6KQ7D685|1637394-01-4|2-Pyridinamine, 3-(difluoromethoxy)-5-(2-(3,3-difluoro-1-pyrrolidinyl)-6-(1S,4S)-2-oxa-5-azabicyclo(2.2.1)hept-5-yl-4-pyrimidinyl)-|CHEMBL3732012|SCHEMBL16210454|GTPL11506|GDC0134|SKMKJBYBPYBDMN-RYU
Specifications & PurityMoligand™
GradeMoligand™
Action TypeINHIBITOR
Mechanism of actionInhibitor of mitogen-activated protein kinase kinase kinase 12

Associated Targets

MAP3K13 Tchem Mitogen-activated protein kinase kinase kinase 13 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

MAP3K12 Tchem Mitogen-activated protein kinase kinase kinase 12 2 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

Names and Identifiers

INCHI InChI=1S/C19H20F4N6O2/c20-17(21)31-14-3-10(6-25-16(14)24)13-5-15(29-7-12-4-11(29)8-30-12)27-18(26-13)28-2-1-19(22,23)9-28/h3,5-6,11-12,17H,1-2,4,7-9H2,(H2,24,25)/t11-,12-/m0/s1
InChi Key SKMKJBYBPYBDMN-RYUDHWBXSA-N
Canonical SMILES FC(Oc1cc(cnc1N)c1cc(nc(n1)N1CCC(C1)(F)F)N1C[C@@H]2C[C@H]1CO2)F
Isomeric SMILES C1CN(CC1(F)F)C2=NC(=CC(=N2)N3C[C@@H]4C[C@H]3CO4)C5=CC(=C(N=C5)N)OC(F)F
PubChem CID 86298636

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

Related Documents

References

1. Villanueva MT.  (2017)  Neurodegenerative disease: DLK zips across neurodegeneration..  Nat Rev Drug Discov,  16  (10): (678-679).  [PMID:28935914]

Solution Calculators